Researchers comparing Semax and Selank are usually mapping which compound fits a given neuropeptide research question. This is descriptive reference information about how they differ, not guidance or a recommendation. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.
| Semax | Selank | |
|---|---|---|
| Type | Synthetic heptapeptide (ACTH-derived sequence) | Synthetic heptapeptide (tuftsin-derived sequence) |
| Primary research area | Neurotrophic and neurochemistry research models | Anxiolytic-pathway and immunomodulation research models |
| Handling | Lyophilized; reconstitute with BAC/sterile water, store frozen | Lyophilized; reconstitute with BAC/sterile water, store frozen |
Semax is a synthetic peptide derived from a fragment of ACTH. It is used as a reference compound in neurochemistry and neurotrophic-factor research in cell-culture and rodent models.
Semax product page and batch COA · Semax reconstitution guide
Selank is a synthetic peptide based on the immunomodulatory peptide tuftsin. In laboratory models it is studied in the context of anxiolytic pathways and immune signaling.
Selank product page and batch COA
Both are short synthetic neuropeptides but derive from different parent sequences and are studied in different pathways: Semax in neurotrophic/neurochemistry contexts, Selank in anxiolytic and immunomodulation contexts. Selection follows the research question, with no comparative human effect claimed.
Both are synthetic heptapeptides but from different parent peptides: Semax is ACTH-derived and studied in neurotrophic research; Selank is tuftsin-derived and studied in anxiolytic-pathway and immunomodulation research.
No. They share a peptide format but have different sequences, origins, and research contexts.
No. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.